| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |